R & D

Intellectual Property

16 PCT patent applications for core innovations.

Number

First Submission Date

Application No

1

2017/07/05

PCT/CN2018/094441

2

2019/01/10

PCT/CN2020/071337

3

2021/08/06

PCT/CN2018/111247

4

2018/09/14

PCT/CN2019/105832

5

2017/07/05

PCT/CN2018/094441

6

2017/05/28

PCT/CN2019/088593

7

2017/07/05

PCT/CN2020/114828

8

2017/12/02

PCT/CN2020/133436

9

2017/03/17

PCT/CN2021/081361

10

2017/03/17

PCT/CN2021/081362

11

2017/12/02

PCT/CN2020/133438

12

2017/12/12

PCT/CN2020/133439

R & D pipeline

3 granted invention patents in China and 21 international granted invention patents.

R & D pipeline

Pipeline: Addressing the Most Critical Unmet Clinical Needs — Phase II stage

R & D pipeline
EnliTISA

Tel:+86-021-33758853

Add:Room 201, 202, 203, BuildingA,  Block1, No. 800, Qingdai Road, Pudong New District, Shanghai

Contact：Dr. Gu Ming

E-mail： bdservice@tisatide.com

Copyright ©2022  EnliTISA (Shanghai) Pharmaceutical Co., Ltd. | SEO    沪ICP备2022023966号-1  Powered by www.300.cn